BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 29104317)

  • 1. Comparison of human cytochrome P450 1A1-catalysed oxidation of benzo[
    Stiborová M; Indra R; Moserová M; Bořek-Dohalská L; Hodek P; Frei E; Kopka K; Schmeiser HH; Arlt VM
    Monatsh Chem; 2017; 148(11):1959-1969. PubMed ID: 29104317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NADH:Cytochrome b5 Reductase and Cytochrome b5 Can Act as Sole Electron Donors to Human Cytochrome P450 1A1-Mediated Oxidation and DNA Adduct Formation by Benzo[a]pyrene.
    Stiborová M; Indra R; Moserová M; Frei E; Schmeiser HH; Kopka K; Phillips DH; Arlt VM
    Chem Res Toxicol; 2016 Aug; 29(8):1325-34. PubMed ID: 27404282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NADPH- and NADH-dependent metabolism of and DNA adduct formation by benzo[
    Stiborová M; Indra R; Moserová M; Šulc M; Hodek P; Frei E; Schmeiser HH; Arlt VM
    Monatsh Chem; 2016; 147():847-855. PubMed ID: 27110038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of human cytochrome P450 1A1-mediated oxidation of benzo[a]pyrene by NADPH:cytochrome P450 oxidoreductase and cytochrome b5.
    Indra R; Moserova M; Kroftova N; Sulc M; Martinkova M; Adam V; Eckschlager T; Kizek R; Arlt VM; Stiborova M
    Neuro Endocrinol Lett; 2014; 35 Suppl 2():105-13. PubMed ID: 25638374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytochrome b5 and epoxide hydrolase contribute to benzo[a]pyrene-DNA adduct formation catalyzed by cytochrome P450 1A1 under low NADPH:P450 oxidoreductase conditions.
    Stiborová M; Moserová M; Černá V; Indra R; Dračínský M; Šulc M; Henderson CJ; Wolf CR; Schmeiser HH; Phillips DH; Frei E; Arlt VM
    Toxicology; 2014 Apr; 318():1-12. PubMed ID: 24530354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochrome
    Stiborová M; Indra R; Frei E; Kopečková K; Schmeiser HH; Eckschlager T; Adam V; Heger Z; Arlt VM; Martínek V
    Monatsh Chem; 2017; 148(11):1983-1991. PubMed ID: 29104319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion of cytochrome P450 oxidoreductase enhances metabolism and DNA adduct formation of benzo[a]pyrene in Hepa1c1c7 cells.
    Reed L; Jarvis IWH; Phillips DH; Arlt VM
    Mutagenesis; 2019 Dec; 34(5-6):413-420. PubMed ID: 31612222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidation of carcinogenic benzo[a]pyrene by human and rat cytochrome P450 1A1 and its influencing by cytochrome b5 - a comparative study.
    Indra R; Moserova M; Sulc M; Frei E; Stiborova M
    Neuro Endocrinol Lett; 2013; 34 Suppl 2():55-63. PubMed ID: 24362093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced DNA adduct formation by benzo[a]pyrene in human liver cells lacking cytochrome P450 oxidoreductase.
    Reed L; Jarvis IWH; Phillips DH; Arlt VM
    Mutat Res Genet Toxicol Environ Mutagen; 2020 Apr; 852():503162. PubMed ID: 32265041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of individual cytochrome P450 enzymes on oxidative metabolism of benzo[a]pyrene in human livers.
    Šulc M; Indra R; Moserová M; Schmeiser HH; Frei E; Arlt VM; Stiborová M
    Environ Mol Mutagen; 2016 Apr; 57(3):229-35. PubMed ID: 26919089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exposure to benzo[a]pyrene of Hepatic Cytochrome P450 Reductase Null (HRN) and P450 Reductase Conditional Null (RCN) mice: Detection of benzo[a]pyrene diol epoxide-DNA adducts by immunohistochemistry and 32P-postlabelling.
    Arlt VM; Poirier MC; Sykes SE; John K; Moserova M; Stiborova M; Wolf CR; Henderson CJ; Phillips DH
    Toxicol Lett; 2012 Sep; 213(2):160-6. PubMed ID: 22759596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exposure to endocrine disruptors 17alpha-ethinylestradiol and estradiol influences cytochrome P450 1A1-mediated genotoxicity of benzo[a]pyrene and expression of this enzyme in rats.
    Stiborová M; Dračínská H; Bořek-Dohalská L; Klusoňová Z; Holecová J; Martínková M; Schmeiser HH; Arlt VM
    Toxicology; 2018 May; 400-401():48-56. PubMed ID: 29649501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochrome b
    Reed L; Mrizova I; Barta F; Indra R; Moserova M; Kopka K; Schmeiser HH; Wolf CR; Henderson CJ; Stiborova M; Phillips DH; Arlt VM
    Arch Toxicol; 2018 Apr; 92(4):1625-1638. PubMed ID: 29368147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of cytochrome b5 in the oxidation of testosterone and nifedipine by recombinant cytochrome P450 3A4 and by human liver microsomes.
    Yamazaki H; Nakano M; Imai Y; Ueng YF; Guengerich FP; Shimada T
    Arch Biochem Biophys; 1996 Jan; 325(2):174-82. PubMed ID: 8561495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Requirements for cytochrome b5 in the oxidation of 7-ethoxycoumarin, chlorzoxazone, aniline, and N-nitrosodimethylamine by recombinant cytochrome P450 2E1 and by human liver microsomes.
    Yamazaki H; Nakano M; Gillam EM; Bell LC; Guengerich FP; Shimada T
    Biochem Pharmacol; 1996 Jul; 52(2):301-9. PubMed ID: 8694855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ellipticine and benzo(a)pyrene increase their own metabolic activation via modulation of expression and enzymatic activity of cytochromes P450 1A1 and 1A2.
    Aimová D; Poljaková J; Kotrbová V; Moserová M; Frei E; Arlt VM; Stiborová M
    Interdiscip Toxicol; 2008 Sep; 1(2):160-8. PubMed ID: 21218107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzo[
    Dračínská H; Indra R; Jelínková S; Černá V; Arlt VM; Stiborová M
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of a human cytochrome P450 1A1: rat NADPH-cytochrome P450 reductase fusion protein cDNA and expression in Escherichia coli, purification, and catalytic properties of the enzyme in bacterial cells and after purification.
    Chun YJ; Shimada T; Guengerich FP
    Arch Biochem Biophys; 1996 Jun; 330(1):48-58. PubMed ID: 8651703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. cDNA-directed expression of human cytochrome P450 CYP1A1 using baculovirus. Purification, dependency on NADPH-P450 oxidoreductase, and reconstitution of catalytic properties without purification.
    Buters JT; Shou M; Hardwick JP; Korzekwa KR; Gonzalez FJ
    Drug Metab Dispos; 1995 Jul; 23(7):696-701. PubMed ID: 7587956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dioxin suppresses benzo[a]pyrene-induced mutations and DNA adduct formation through cytochrome P450 1A1 induction and (±)-anti-benzo[a]pyrene-7,8-diol-9,10-epoxide inactivation in human hepatoma cells.
    Shiizaki K; Kawanishi M; Yagi T
    Mutat Res; 2013 Jan; 750(1-2):77-85. PubMed ID: 23036853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.